Completed PHASE3 INTERVENTIONAL 2-arm NCT00894959

Efficacy and Safety of Sodium Heparin in Patients

Randomized Clinical Trial of Sodium Heparin Effectiveness and Security in Patients Submitted to Heart Surgery Using Bypass

Sponsor: Azidus Brasil

Conditions Cardiac Surgery

Interventions Heparin sodium APP Heparin sodium Blausiegel 1

Updated 5 times since 2017 Last updated: Feb 22, 2013 Started: Jul 31, 2009 Primary completion: Sep 30, 2009 Completion: Dec 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00894959, this PHASE3 trial focuses on Cardiac Surgery and remains completed. Sponsored by Azidus Brasil, it has been updated 5 times since 2009, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jul 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Azidus Brasil

Data source: Azidus Brasil

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Valinhos, Brazil